In-Stent Yellow Plaque at 1 Year After Implantation Is Associated With Future Event of Very Late Stent Failure

Yasunori Ueda; Koshi Matsuo; Yuji Nishimoto; Ryuta Sugihara; Akio Hirata; Takayoshi Nemoto; Masato Okada; Ayaka Murakami; Kazunori Kashiwase; Kazuhisa Kodama

doi:10.1016/j.jcin.2014.12.239

journal article Open Access May 01, 2015

In-Stent Yellow Plaque at 1 Year After Implantation Is Associated With Future Event of Very Late Stent Failure

Yasunori Ueda Koshi Matsuo Yuji Nishimoto

Ryuta Sugihara Akio Hirata Takayoshi Nemoto Masato Okada

Ayaka Murakami Kazunori Kashiwase Kazuhisa Kodama

JACC: Cardiovascular Interventions Vol. 8 No. 6 pp. 814-821 · Elsevier BV

View at Publisher Save 10.1016/j.jcin.2014.12.239

Topics

No keywords indexed for this article. Browse by subject →

References

33

[1]

Daemen "Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study" Lancet (2007) 10.1016/s0140-6736(07)60314-6

[2]

Eisenstein J Am Coll Cardiol Intv (2009) 10.1016/j.jcin.2009.10.011

[3]

Kandzari J Am Coll Cardiol Intv (2011) 10.1016/j.jcin.2010.12.014

[4]

Leon J Am Coll Cardiol Intv (2009) 10.1016/j.jcin.2009.10.008

[5]

Garg J Am Coll Cardiol Intv (2009) 10.1016/j.jcin.2009.10.002

[6]

Stone Circulation (2009) 10.1161/circulationaha.108.803528

[7]

Stone "Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial" J Am Coll Cardiol (2011) 10.1016/j.jacc.2011.02.022

[8]

Onuma "Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trial" EuroIntervention (2013) 10.4244/eijv8i9a161

[9]

Ueda "Assessment of plaque vulnerability by angioscopic classification of plaque color" Am Heart J (2004) 10.1016/j.ahj.2004.03.047

[10]

Ueda "The healing process of infarct-related plaques: insights from 18 months of serial angioscopic follow-up" J Am Coll Cardiol (2001) 10.1016/s0735-1097(01)01673-4

[11]

Yokoyama "Extended follow-up by serial angioscopic observation for bare-metal stents in native coronary arteries: from healing response to atherosclerotic transformation of neointima" Circ Cardiovasc Interv (2009) 10.1161/circinterventions.109.854679

[12]

Hasegawa "Histopathological findings of new in-stent lesions developed beyond five years" Catheter Cardiovasc Interv (2006)

[13]

Nakazawa "One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis" J Am Coll Cardiol Img (2009) 10.1016/j.jcmg.2009.01.011

[14]

Ueda "Neointimal coverage of stents in human coronary arteries observed by angioscopy" J Am Coll Cardiol (1994) 10.1016/0735-1097(94)90417-0

[15]

Higo "Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study" J Am Coll Cardiol Img (2009) 10.1016/j.jcmg.2008.12.026

[16]

Oyabu "Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent" Am Heart J (2006) 10.1016/j.ahj.2006.07.025

[17]

Matsuo "A higher colour grade yellow plaque was detected at one year after implantation of an everolimus-eluting stent than after a zotarolimus-eluting stent" Heart Asia (2013) 10.1136/heartasia-2013-010378

[18]

Holmes "Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis" Circulation (2004) 10.1161/01.cir.0000112572.57794.22

[19]

Weisz "Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial" J Am Coll Cardiol (2009) 10.1016/j.jacc.2009.01.050

[20]

Stone "One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial" Circulation (2004) 10.1161/01.cir.0000127110.49192.72

[21]

Ellis "Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent)" J Am Coll Cardiol Intv (2009) 10.1016/j.jcin.2009.10.003

[22]

Fajadet "Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial" Circulation (2006) 10.1161/circulationaha.105.591206

[23]

Fajadet "Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study" EuroIntervention (2010) 10.4244/eijv6i5a95

[24]

Stone "Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial" JAMA (2008) 10.1001/jama.299.16.1903

[25]

Finn "Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization" Circulation (2007) 10.1161/circulationaha.107.693739

[26]

Liistro "First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome" Circulation (2002) 10.1161/01.cir.0000016042.69606.61

[27]

Natsuaki "Impact of statin therapy on late target lesion revascularization after sirolimus-eluting stent implantation (from the CREDO-Kyoto Registry Cohort-2)" Am J Cardiol (2012) 10.1016/j.amjcard.2012.01.350

[28]

Choi "Predictors of early and late target lesion revascularization after drug-eluting stent implantation" J Interv Cardiol (2013) 10.1111/joic.12001

[29]

Kubo "Implication of plaque color classification for assessing plaque vulnerability: a coronary angioscopy and optical coherence tomography investigation" J Am Coll Cardiol Intv (2008) 10.1016/j.jcin.2007.11.001

[30]

Ohtani "Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome: detection of vulnerable patients by angioscopy" J Am Coll Cardiol (2006) 10.1016/j.jacc.2006.01.064

[31]

Matsuo "Very late stent thrombosis at 2.5 years after sirolimus-eluting stent implantation with prior angioscopic image of culprit lesion: a case report" J Cardiol Cases (2012) 10.1016/j.jccase.2011.10.009

[32]

Kang "OCT analysis in patients with very late stent thrombosis" J Am Coll Cardiol Img (2013) 10.1016/j.jcmg.2013.02.006

[33]

Kang "Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation" Circulation (2011) 10.1161/circulationaha.110.988436

Cited By

77

JCS/CVIT/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular Dysfunction

Seiji Hokimoto, Koichi Kaikita · 2023

Circulation Journal

Metrics

77

Citations

33

References

Details

Published: May 01, 2015
Vol/Issue: 8(6)
Pages: 814-821
License: View

Authors

Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Chiba 277-8561, Japan

Cite This Article

Yasunori Ueda, Koshi Matsuo, Yuji Nishimoto, et al. (2015). In-Stent Yellow Plaque at 1 Year After Implantation Is Associated With Future Event of Very Late Stent Failure. JACC: Cardiovascular Interventions, 8(6), 814-821. https://doi.org/10.1016/j.jcin.2014.12.239

In-Stent Yellow Plaque at 1 Year After Implantation Is Associated With Future Event of Very Late Stent Failure

You May Also Like